bioRxiv Science⌕ Search

Biology subjects

McGuire, B. E.

Publications and source records attributed to McGuire, B. E..

3 recordsLinked to original sources

The complete {lambda}-carrageenan depolymerization cascade from a marine Pseudoalteromonad revealed by structural analysis of the enzymes.

Carrageenans are a complex group of polysaccharides derived from the cell walls of red macroalgae. They are an abundant, yet recalcitrant nutrient source for most marine heterotrophic bacteria. Some member species of the Pseudoalteromonas genus are effective at metabolizing carrageenan. However, the enzymatic pathway for {lambda}-carrageenan, one of the most sulfated naturally occurring polysaccharides, remains unknown. Using detailed structural analysis by X-ray crystallography we reveal the sophisticated and cyclic enzymatic cascade deployed by Pseudoalteromonas distincta (strain U2A) to utilize {lambda}-carrageenan. The cascade incorporates ten glycoside hydrolases and five sulfatases that are specific for {lambda}-carrageenan and cooperate to completely deconstruct this polysaccharide, thus yielding galactose monosaccharides for subsequent energy production. The detailed molecular understanding of {lambda}-carrageenan depolymerisation provided includes structural evidence for a lesser described sulfatase catalytic mechanism and elucidation of a distinct catabolic cascade that is unique from previously described carrageenan metabolic pathways. This insight also holds potential for the application of enzymatic logic in the generation of high value products from abundant natural biopolymers, such as carrageenans.

biochemistry↗

Genomic analysis of laboratory-evolved, heat-adapted Escherichia coli strains

Adaptive laboratory evolution to high incubation temperatures represents a complex evolutionary problem, and each study to date performed in Escherichia coli has resulted in a different set of mutations. We performed adaptive laboratory evolution of E. coli to heat by passaging a culture at elevated temperatures for 150 days. Throughout the adaptive evolution we expressed a set of genes that induce hyper-mutagenesis. These growth conditions yielded a strain with a maximum growth temperature approximately 2 {degrees}C above that of the parental strain. We preserved evolved isolates weekly and obtained and analyzed whole-genome sequencing data for three isolates from different time points. We identified hundreds of mutations, including mutations in components of the RNA polymerase (RpoB, RpoC and RpoD), Rho, and the heat shock proteins GroES, GroEL, DnaK, ClpB, IbpA and HslU. We compared the proteomes of the starting strain and final strain grown at 37 {degrees}C and 42.5 {degrees}C and identified changes in abundance between samples for GroESL, HslVU, DnaK, ClpB and other important proteins. This study details a distinct evolutionary route towards enhanced thermotolerance, contributes to our understanding of adaptation to heat in Escherichia coli and may provide insights into heat adaptation in other organisms.

evolutionary biology↗

Escherichia coli recombinant expression of SARS-CoV-2 protein fragments.

We have developed a method for the inexpensive, high-level expression of antigenic protein fragments of SARS-CoV-2 proteins in Escherichia coli. Our approach used the thermophilic family 9 carbohydrate-binding module (CBM9) as an N-terminal carrier protein and affinity tag. The CBM9 module was joined to SARS-CoV-2 protein fragments via a flexible proline-threonine linker, which proved to be resistant to E. coli proteases. Two CBM9-spike protein fragment fusion proteins and one CBM9-nucleocapsid fragment fusion protein largely resisted protease degradation, while most of the CBM9 fusion proteins were degraded at some site in the SARS-CoV-2 protein fragment. All fusion proteins were expressed in E. coli at about 0.1 g/L, and could be purified with a single affinity binding step using inexpensive cellulose powder. Three purified CBM9-SARS-CoV-2 fusion proteins were tested and found to bind antibody directed to the appropriate SARS-CoV-2 antigenic region. The largest intact CBM9 fusion protein incorporates spike protein amino acids 540-588, which is a conserved region immediately C-terminal to the receptor binding domain that is widely recognized by human convalescent sera and contains a putative protective epitope.

microbiology↗